Elevated serum vascular endothelial growth factor in patients with hormone-escaped prostate cancer.
OBJECTIVE: To investigate the role of serum vascular endothelial growth factor (VEGF) in the assessment of patients with prostate cancer. Patients, subjects and methods Serum from 78 men was assayed for VEGF using a commercially available enzyme-linked immunosorbent assay kit. Forty-eight patients h...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2000
|
| _version_ | 1826281878388211712 |
|---|---|
| author | Jones, A Fujiyama, C Turner, K Fuggle, S Cranston, D Bicknell, R Harris, A |
| author_facet | Jones, A Fujiyama, C Turner, K Fuggle, S Cranston, D Bicknell, R Harris, A |
| author_sort | Jones, A |
| collection | OXFORD |
| description | OBJECTIVE: To investigate the role of serum vascular endothelial growth factor (VEGF) in the assessment of patients with prostate cancer. Patients, subjects and methods Serum from 78 men was assayed for VEGF using a commercially available enzyme-linked immunosorbent assay kit. Forty-eight patients had a histopathological diagnosis of prostate cancer (16 local disease, 32 metastatic), nine had benign prostatic hyperplasia (BPH) and 21 were healthy controls. RESULTS: The mean serum VEGF level was significantly higher in patients with hormone-escaped prostate cancer than in all other groups (P |
| first_indexed | 2024-03-07T00:35:26Z |
| format | Journal article |
| id | oxford-uuid:8139a521-feae-4325-a4e9-b0c69b0f99dc |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T00:35:26Z |
| publishDate | 2000 |
| record_format | dspace |
| spelling | oxford-uuid:8139a521-feae-4325-a4e9-b0c69b0f99dc2022-03-26T21:28:59ZElevated serum vascular endothelial growth factor in patients with hormone-escaped prostate cancer.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:8139a521-feae-4325-a4e9-b0c69b0f99dcEnglishSymplectic Elements at Oxford2000Jones, AFujiyama, CTurner, KFuggle, SCranston, DBicknell, RHarris, AOBJECTIVE: To investigate the role of serum vascular endothelial growth factor (VEGF) in the assessment of patients with prostate cancer. Patients, subjects and methods Serum from 78 men was assayed for VEGF using a commercially available enzyme-linked immunosorbent assay kit. Forty-eight patients had a histopathological diagnosis of prostate cancer (16 local disease, 32 metastatic), nine had benign prostatic hyperplasia (BPH) and 21 were healthy controls. RESULTS: The mean serum VEGF level was significantly higher in patients with hormone-escaped prostate cancer than in all other groups (P |
| spellingShingle | Jones, A Fujiyama, C Turner, K Fuggle, S Cranston, D Bicknell, R Harris, A Elevated serum vascular endothelial growth factor in patients with hormone-escaped prostate cancer. |
| title | Elevated serum vascular endothelial growth factor in patients with hormone-escaped prostate cancer. |
| title_full | Elevated serum vascular endothelial growth factor in patients with hormone-escaped prostate cancer. |
| title_fullStr | Elevated serum vascular endothelial growth factor in patients with hormone-escaped prostate cancer. |
| title_full_unstemmed | Elevated serum vascular endothelial growth factor in patients with hormone-escaped prostate cancer. |
| title_short | Elevated serum vascular endothelial growth factor in patients with hormone-escaped prostate cancer. |
| title_sort | elevated serum vascular endothelial growth factor in patients with hormone escaped prostate cancer |
| work_keys_str_mv | AT jonesa elevatedserumvascularendothelialgrowthfactorinpatientswithhormoneescapedprostatecancer AT fujiyamac elevatedserumvascularendothelialgrowthfactorinpatientswithhormoneescapedprostatecancer AT turnerk elevatedserumvascularendothelialgrowthfactorinpatientswithhormoneescapedprostatecancer AT fuggles elevatedserumvascularendothelialgrowthfactorinpatientswithhormoneescapedprostatecancer AT cranstond elevatedserumvascularendothelialgrowthfactorinpatientswithhormoneescapedprostatecancer AT bicknellr elevatedserumvascularendothelialgrowthfactorinpatientswithhormoneescapedprostatecancer AT harrisa elevatedserumvascularendothelialgrowthfactorinpatientswithhormoneescapedprostatecancer |